Cardiometabolic
Europe’s Safe Hearts Plan Makes Prevention a Political Test
The EU’s first cardiovascular health plan puts prevention, screening, personalised monitoring, AI and inequalities into one agenda, turning heart health into a test of whether Europe can act before disease becomes crisis.
AI Diabetes Tools Need Infrastructure Before Scale
Diabetes Tech Moves From Optional Add-On to Earlier Care
Obesity Care Starts Moving Beyond BMI
Canada’s Generic Semaglutide Approval Tests GLP-1 Affordability
India’s Obesity Campaign Dispute Tests the Line Between Awareness and Promotion
England’s Tirzepatide Rollout Shows Approval Is Not Access
Medicare’s GLP-1 Bridge Turns Obesity Coverage Into a Public-Payer Experiment
WHO Makes Obesity Treatment a Global Access Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.